在COVID-19后的持续性呼吸障碍中,吸气和呼吸肌肉力量训练是持续性呼吸障碍
Sandra P Morgan1,2, Bini Thomas1, Carmen S Rodriguez1
1University of South Florida, Tampa, USA.
在COVID-19幸存者中,在家进行呼吸肌肉力量训练显著减少呼吸不良和改善肺功能. 这项为期12周的计划被发现对于COVID-19后出现持续症状的患者来说是可行的和可以接受的.
科学领域:
- 肺部病理学 肺部病理学
- 康复医学 康复医学 康复医学
- 传染性疾病 传染性疾病
背景情况:
- COVID-19可能导致病毒诱导的肌肉病变,导致持续性呼吸障碍.
- 呼吸道肌肉衰弱是COVID-19后常见的症状,影响生活质量.
- 呼吸道肌肉力量训练 (RMST) 在治疗病毒后呼吸道并发症方面表现有前途.
研究的目的:
- 为了评估12周的家庭RMST计划在减少COVID-19后幸存者的呼吸障碍方面的有效性.
- 评估这种家庭干预的可行性和可接受性.
- 研究RMST对肺功能和功能能力的影响.
主要方法:
- 一个单组试验涉及成年人超过4周后急性COVID-19疾病.
- 参与者接受了为期12周的家庭RMST计划,在基线,6周和12周进行了面对面的评估.
- 结果措施包括呼吸困难,肺部症状,生活质量,肺功能测试和6分钟步行测试.
主要成果:
- 观察到呼吸障碍 (p=0.005) 和肺部症状 (p<0.001) 的显著减少.
- 生活质量指数得分 (p=0.013) 和视觉模拟尺度评分 (p=0.004) 显著改善.
- 在峰值吸气流 (p<0.001),FEV1 (p<0.001),胸部膨胀 (p<0.001) 和6分钟的步行距离 (p<0.001) 中注意到了显著的改善.
- 遵守率超过95%,可行性和可接受性得分高.
结论:
- 家庭RMST是一种有效和可接受的独立策略,用于减少COVID-19后幸存者的持续性呼吸障碍.
- 这种干预措施对肺功能和生活质量有显著的益处.
- 对于从COVID-19中恢复过来的个人来说,RMST提供了一个可行的康复选择.
更多相关视频
09:42Acquisition and Semi-Automated Analysis of Respiratory Muscle Surface Electromyography
Published on: January 24, 2025
12:59Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
相关概念视频
Mechanism of Breathing III: The Accessory Muscles
The respiratory system is a complex network that relies on primary respiratory muscles like the diaphragm, but also involves accessory muscles to enhance lung expansion and airflow during both inhalation and exhalation.
Enhancing Inhalation with Accessory Muscles:
Accessory muscles such as the sternocleidomastoid, scalene, intercostal, and abdominal muscles are crucial when additional respiratory effort is required, such as during deep...
COPD: Management Using Bronchodilators and Corticosteroids
Chest Physiotherapy
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
